Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1...
75 insider purchases on record · latest filing 2026-10-06.
Insiders have also filed 913 sale transactions at DYN.